| Literature DB >> 33339862 |
Małgorzata Chmielewska1, Piotr Janusz2, Mirosław Andrusiewicz3, Tomasz Kotwicki2, Małgorzata Kotwicka3.
Abstract
Idiopathic scoliosis (IS) is one of the most common spinal disorders in adolescents. Despite many studies, the etiopathogenesis of IS is still poorly understood. In recent years, the role of epigenetic factors in the etiopathogenesis of IS has been increasingly investigated. It has also been postulated that the development and progression of the disease is related to gender and puberty, and could be associated with estrogen action. Estrogen hormones act via estrogen receptor 1 (ESR1) and estrogen receptor 2 (ESR2). It has been suggested that ESR2 expression is dependent on methylation within its gene promoter. So far, no studies have evaluated local, tissue-specific DNA methylation in patients with IS. Thus, our study aimed to analyze the methylation and expression level of ESR2 in the paraspinal muscles of the convex and concave side of the IS curvature. The methylation level within ESR2 promoter 0N, but not exon 0N, was significantly higher on the concave side of the curvature compared to the convex side. There was no significant correlation between ESR2 expression and methylation level in the promoter 0N on the convexity of thoracic scoliosis, whereas, on the concave side of the curvature, we observed a moderate negative correlation. There was no difference in the methylation levels of the ESR2 promoter and exon 0N between groups of patients with Cobb angle ≤ 70° and > 70° on the concave and convex side of the curvature. We also found no statistically significant correlation between the Cobb angle value and the mean methylation level in either the ESR2 promoter or exon 0N on the convex or concave side of the curvature. Our findings demonstrate that DNA methylation at the ESR2 promoter in deep paravertebral muscle tissue is associated with the occurrence but not with the severity of idiopathic scoliosis.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33339862 PMCID: PMC7749113 DOI: 10.1038/s41598-020-78454-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1DNA methylation level within ESR2 promoter 0N (A) and exon 0N (B) in deep paravertebral muscles.
Figure 2DNA methylation level in seven CpG sites localized within ESR2 promoter 0N in deep paravertebral muscles.
Figure 3Correlation between ESR2 expression and mean methylation level in promoter 0N and exon 0N on the convex (A,C) and concave (B,D) side of the curvature.
Figure 4Correlation between ESR2 expression and methylation level at each CpG site in promoter 0N on the convex (A) and concave (B) side of the curvature.
Figure 5Correlation between ESR2 expression and methylation level at each CpG site in exon 0N on the convex (A) and concave (B) side of the curvature.
Figure 6DNA methylation level within ESR2 promoter 0N on the convex (A) and concave side of the curvature (B) and exon 0N on the convex (C) and concave (D) side of the curvature in the group of patients with Cobb angle ≤ 70° and > 70°.
Primer sequences and location.
| Primer | Sequence | Tm (°C) | GC (%) | PCR product size | Location with respect to TSS | Location with respect to ATG | ||
|---|---|---|---|---|---|---|---|---|
| →PCR | GGTATTTTTTAGGATTTGGTTGGAAATGTA | 30 | 60,9 | 30,0 | 276 bp | − 239 | − 11,663 | |
| ←PCRB | ACTTAACCATAAACCCCTTCTTCCTTT | 27 | 58,9 | 37,0 | + 37 | − 11,387 | ||
| SEQ | ATATTTTTAGGTTTTATTTTAGAT | 24 | 40,7 | 12,5 | – | − 209 | − 11,633 | |
| →PCR | GGAGGTTGAGAGAAATAATTGTTTTTTGA | 29 | 57,7 | 31,0 | 253 bp | + 115 | − 11,309 | |
| ←PCRB | AAACACACCCACCTTACCTTCTCTA | 25 | 58,3 | 44,0 | + 368 | − 11,057 | ||
| SEQ | GTTTTTTGAAATTTGTAGGG | 20 | 44,8 | 30,0 | – | + 135 | − 11,289 |
→PCR, forward primer; ←PCR, reverse primer; B, biotinylated primer; Tm, melting temperature, GC, guanine-cytosine content; bp, base pairs; TSS, transcription start site; ATG, start codon; SEQ, sequencing primer.
PCR mixture content and thermal profile of the reactions.
| PCR reaction mixture | ||||
|---|---|---|---|---|
| Component | Initial concentration | Volume added | Final concentration | Mixture volume |
| ZymoTaq™ Premix | 2x | 5 µl | 1x | 10 µl |
| →PCR | 10 µM | 1 µl | 1 µM | |
| ←PCR | 10 µM | 1 µl | 1 µM | |
| DNA | 100 ng/µl | 0,2 µl | 2 ng/µl | |
| nuclease-free water | 2,8 µl | |||
| 1 | initial denaturation | 10 min., 95 °C | ||
| 37 | denaturation | 30 s., 95 °C | ||
| annealing | 30 s., 54 °C | |||
| extension | 60 s., 72 °C | |||
| 1 | final extension | 7 min., 72 °C | ||
| 1 | hold | ∞, 4 °C | ||
→PCR, forward primer; ←PCR, reverse primer; min., minutes, s., seconds.